We are live on ! Find out more
WA

WestEnd Advisors Portfolio holdings

AUM $4.14B
1-Year Est. Return 15.99%
This Fund
S&P 500
This Quarter Est. Return
+5.77%
1 Year Est. Return
+15.99%
3 Year Est. Return
+49.16%
5 Year Est. Return
+46.23%
10 Year Est. Return
+187.39%
AUM
$1.98B
AUM Growth
-$59.7M
Cap. Flow
-$151M
Cap. Flow %
-7.64%
Top 10 Hldgs %
50.76%
Holding
36
New
2
Increased
14
Reduced
16
Closed
4

Top Buys

1
HCA icon
HCA Healthcare
HCA
+$94.9M
2
CPRI icon
Capri Holdings
CPRI
+$64.5M
3
CMCSA icon
Comcast
CMCSA
+$44.6M
4
ORCL icon
Oracle
ORCL
+$3.63M
5
ADBE icon
Adobe
ADBE
+$3.09M

Sector Composition

1 Healthcare 30.1%
2 Consumer Discretionary 24.96%
3 Technology 24.66%
4 Consumer Staples 10.07%
5 Communication Services 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELG
1
DELISTED
Celgene Corp
CELG
$104M 5.25%
1,096,442
-85,909
-7% -$7.75M
EBAY icon
2
eBay
EBAY
$49.2B
$104M 5.23%
4,343,223
-532,384
-11% -$11.8M
COST icon
3
Costco
COST
$419B
$103M 5.18%
818,421
-61,320
-7% -$7.41M
HCA icon
4
HCA Healthcare
HCA
$85.6B
$101M 5.12%
+1,436,434
New +$94.9M
ESRX
5
DELISTED
Express Scripts Holding Company
ESRX
$99.6M 5.03%
1,409,494
-69,604
-5% -$4.96M
ADBE icon
6
Adobe
ADBE
$93.5B
$99.3M 5.02%
1,435,144
+43,650
+3% +$3.09M
AAPL icon
7
Apple
AAPL
$4.89T
$98.9M 5%
3,927,420
-522,800
-12% -$12.8M
DIS icon
8
Walt Disney
DIS
$173B
$98.9M 5%
1,110,740
-111,824
-9% -$9.86M
NKE icon
9
Nike
NKE
$66.1B
$98.5M 4.98%
2,209,562
-473,824
-18% -$18.8M
CVS icon
10
CVS Health
CVS
$136B
$98.2M 4.96%
1,234,222
-93,673
-7% -$7.38M
ORCL icon
11
Oracle
ORCL
$358B
$98M 4.95%
2,560,361
+89,655
+4% +$3.63M
CPRI icon
12
Capri Holdings
CPRI
$1.94B
$97.9M 4.95%
1,371,888
+801,946
+141% +$64.5M
TJX icon
13
TJX Companies
TJX
$171B
$97.6M 4.93%
3,298,204
-415,196
-11% -$11.7M
GILD icon
14
Gilead Sciences
GILD
$169B
$97.2M 4.91%
913,398
-333,193
-27% -$32.6M
EL icon
15
Estee Lauder
EL
$30B
$96.8M 4.89%
1,295,221
-57,037
-4% -$4.29M
JWN
16
DELISTED
Nordstrom
JWN
$96.5M 4.87%
1,411,303
-83,877
-6% -$5.78M
EMC
17
DELISTED
EMC CORPORATION
EMC
$96.2M 4.86%
3,286,144
-566,626
-15% -$16.3M
QCOM icon
18
Qualcomm
QCOM
$180B
$95.8M 4.84%
1,281,172
+7,530
+0.6% +$576K
BIIB icon
19
Biogen
BIIB
$30.8B
$95.6M 4.83%
289,062
-31,254
-10% -$10.3M
CMCSA icon
20
Comcast
CMCSA
$86.1B
$95.4M 4.82%
3,549,186
+1,629,418
+85% +$44.6M
VEU icon
21
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$1.65M 0.08%
33,597
+6,099
+22% +$315K
VGT icon
22
Vanguard Information Technology ETF
VGT
$139B
$978K 0.05%
+78,176
New +$971K
XLY icon
23
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.3B
$967K 0.05%
28,986
+10,410
+56% +$352K
SPY icon
24
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$955K 0.05%
4,847
+4,550
+1,532% +$899K
XLV icon
25
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
$817K 0.04%
12,785
+2,321
+22% +$145K

Similar funds

WestEnd Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, WestEnd Advisors held 36 positions worth $1.98B, down 2.9% from $2.04B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

WestEnd Advisors withdrew a net $151M in Q3 2014, closing 4 positions and reducing 16 holdings. Its most notable exit was Mondelez International, an estimated $102M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, WestEnd Advisors opened a new position in HCA Healthcare worth $101M.

  • WestEnd Advisors's largest Q3 2014 buy was HCA Healthcare: 1,436,434 shares worth $101M.
  • WestEnd Advisors added most to Capri Holdings in Q3 2014, an estimated $64.5M increase.
  • WestEnd Advisors's biggest Q3 2014 reduction was Gilead Sciences, cutting an estimated $32.6M.
  • WestEnd Advisors fully exited Mondelez International in Q3 2014, selling an estimated $102M.
  • WestEnd Advisors's ten largest holdings make up 51% of its $1.98B portfolio in Q3 2014.
  • WestEnd Advisors opened 2 new positions and closed 4 in Q3 2014.
  • WestEnd Advisors's portfolio value fell 2.9% quarter-over-quarter to $1.98B.

Based on WestEnd Advisors's 13F filing for Q3 2014, filed 30 Oct 2014.